Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Nuclear Medicine

  Free Subscription


Articles published in Brain

Retrieve available abstracts of 44 articles:
HTML format
Text format



Single Articles


    July 2016
  1. LEWCZUK P, Kornhuber J
    Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
    Brain. 2016.
    PubMed     Text format    


  2. PALMQVIST S, Mattsson N, Hansson O
    Reply: Do we still need positron emission tomography for early Alzheimer's disease diagnosis?
    Brain. 2016.
    PubMed     Text format    


    June 2016
  3. SMITH R, Puschmann A, Scholl M, Ohlsson T, et al
    18F-AV-1451 tau PET imaging correlates strongly with tau neuropathology in MAPT mutation carriers.
    Brain. 2016.
    PubMed     Text format     Abstract available


  4. GORDON BA, Friedrichsen K, Brier M, Blazey T, et al
    The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging.
    Brain. 2016.
    PubMed     Text format     Abstract available


    May 2016
  5. HANSEN AK, Knudsen K, Lillethorup TP, Landau AM, et al
    In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET.
    Brain. 2016.
    PubMed     Text format     Abstract available


  6. SARAZIN M, Lagarde J, Bottlaender M
    Distinct tau PET imaging patterns in typical and atypical Alzheimer's disease.
    Brain. 2016;139.
    PubMed     Text format    


  7. THAL DR, Vandenberghe R
    Monitoring the progression of Alzheimer's disease with tau-PET.
    Brain. 2016;139.
    PubMed     Text format    


    March 2016
  8. HAMELIN L, Lagarde J, Dorothee G, Leroy C, et al
    Early and protective microglial activation in Alzheimer's disease: a prospective study using 18F-DPA-714 PET imaging.
    Brain. 2016.
    PubMed     Text format     Abstract available


  9. OSSENKOPPELE R, Schonhaut DR, Scholl M, Lockhart SN, et al
    Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  10. PALMQVIST S, Mattsson N, Hansson O
    Cerebrospinal fluid analysis detects cerebral amyloid-beta accumulation earlier than positron emission tomography.
    Brain. 2016.
    PubMed     Text format     Abstract available


  11. SCHWARZ AJ, Yu P, Miller BB, Shcherbinin S, et al
    Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.
    Brain. 2016.
    PubMed     Text format     Abstract available


  12. SCHOTT JM, Fox NC
    Inflammatory changes in very early Alzheimer's disease: friend, foe, or don't know?
    Brain. 2016;139.
    PubMed     Text format    


    January 2016
  13. RODRIGUEZ-VIEITEZ E, Saint-Aubert L, Carter SF, Almkvist O, et al
    Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease.
    Brain. 2016.
    PubMed     Text format     Abstract available


  14. JAGUST W
    Is amyloid-beta harmful to the brain? Insights from human imaging studies.
    Brain. 2016;139.
    PubMed     Text format     Abstract available


    November 2015
  15. SCHOLS L, Reimold M, Seidel K, Globas C, et al
    No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    October 2015
  16. FAN Z, Okello AA, Brooks DJ, Edison P, et al
    Longitudinal influence of microglial activation and amyloid on neuronal function in Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  17. MAYA Y, Okumura Y, Kobayashi R, Onishi T, et al
    Preclinical properties and human in vivo assessment of 123I-ABC577 as a novel SPECT agent for imaging amyloid-beta.
    Brain. 2015.
    PubMed     Text format     Abstract available


  18. MCCARTHY A, Lonergan R, Olszewska DA, O'Dowd S, et al
    Closing the tau loop: the missing tau mutation.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  19. NICCOLINI F, Foltynie T, Reis Marques T, Muhlert N, et al
    Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  20. QAMHAWI Z, Towey D, Shah B, Pagano G, et al
    Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  21. NICCOLINI F, Haider S, Reis Marques T, Muhlert N, et al
    Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    September 2015
  22. PORTELIUS E, Zetterberg H, Skillback T, Tornqvist U, et al
    Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


    August 2015
  23. FRINGS L, Hellwig S, Spehl TS, Bormann T, et al
    Asymmetries of amyloid-beta burden and neuronal dysfunction are positively correlated in Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


  24. RAMANAN VK, Risacher SL, Nho K, Kim S, et al
    GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.
    Brain. 2015.
    PubMed     Text format     Abstract available


    July 2015
  25. OSSENKOPPELE R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, et al
    The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features.
    Brain. 2015.
    PubMed     Text format     Abstract available


  26. JUCAITE A, Svenningsson P, Rinne JO, Cselenyi Z, et al
    Effect of the myeloperoxidase inhibitor AZD3241 on microglia: a PET study in Parkinson's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


    June 2015
  27. JACOBSEN JH, Stelzer J, Fritz TH, Chetelat G, et al
    Why musical memory can be preserved in advanced Alzheimer's disease.
    Brain. 2015.
    PubMed     Text format     Abstract available


    May 2015
  28. DAUVILLIERS Y, Peigneux P
    Ictal SPECT in patients with rapid eye movement sleep behaviour disorder.
    Brain. 2015.
    PubMed     Text format    


  29. VILLENEUVE S, Rabinovici GD, Cohn-Sheehy BI, Madison C, et al
    Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation.
    Brain. 2015.
    PubMed     Text format     Abstract available


    March 2015
  30. MURRAY ME, Lowe VJ, Graff-Radford NR, Liesinger AM, et al
    Clinicopathologic and 11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer's disease spectrum.
    Brain. 2015.
    PubMed     Text format     Abstract available


  31. MAYER G, Bitterlich M, Kuwert T, Ritt P, et al
    Ictal SPECT in patients with rapid eye movement sleep behaviour disorder.
    Brain. 2015.
    PubMed     Text format     Abstract available


  32. VEMURI P, Lesnick TG, Przybelski SA, Knopman DS, et al
    Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


  33. LOGGIA ML, Chonde DB, Akeju O, Arabasz G, et al
    Evidence for brain glial activation in chronic pain patients.
    Brain. 2015;138.
    PubMed     Text format     Abstract available


    December 2014
  34. MATTSSON N, Insel PS, Donohue M, Landau S, et al
    Independent information from cerebrospinal fluid amyloid-beta and florbetapir imaging in Alzheimer's disease.
    Brain. 2014.
    PubMed     Text format     Abstract available


  35. GJERLOFF T, Fedorova T, Knudsen K, Munk OL, et al
    Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET.
    Brain. 2014.
    PubMed     Text format     Abstract available


    November 2014
  36. GIANNETTI P, Politis M, Su P, Turkheimer FE, et al
    Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.
    Brain. 2014.
    PubMed     Text format     Abstract available


  37. NIETHAMMER M, Tang CC, Feigin A, Allen PJ, et al
    A disease-specific metabolic brain network associated with corticobasal degeneration.
    Brain. 2014;137.
    PubMed     Text format     Abstract available


    October 2014
  38. JOSEPHS KA, Duffy JR, Strand EA, Machulda MM, et al
    The evolution of primary progressive apraxia of speech.
    Brain. 2014;137.
    PubMed     Text format     Abstract available


    September 2014
  39. HARTLEY SL, Handen BL, Devenny DA, Hardison R, et al
    Cognitive functioning in relation to brain amyloid-beta in healthy adults with Down syndrome.
    Brain. 2014;137.
    PubMed     Text format     Abstract available


    August 2014
  40. GONZALEZ-REDONDO R, Garcia-Garcia D, Clavero P, Gasca-Salas C, et al
    Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    Brain. 2014;137.
    PubMed     Text format     Abstract available


    July 2014
  41. KAS A, Lavault S, Habert MO, Arnulf I, et al
    Feeling unreal: a functional imaging study in patients with Kleine-Levin syndrome.
    Brain. 2014;137.
    PubMed     Text format     Abstract available


    June 2014
  42. VOLKOW ND, Tomasi D, Wang GJ, Studentsova Y, et al
    Brain glucose metabolism in adults with ataxia-telangiectasia and their asymptomatic relatives.
    Brain. 2014;137.
    PubMed     Text format     Abstract available


  43. JAGUST W
    Time for tau.
    Brain. 2014;137.
    PubMed     Text format    


    April 2014
  44. MYERS N, Pasquini L, Gottler J, Grimmer T, et al
    Within-patient correspondence of amyloid-beta and intrinsic network connectivity in Alzheimer's disease.
    Brain. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Nuclear Medicine is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: